Walmart stock rises even as the retailer says the range of outcomes for first-quarter operating income growth had widened ...

A federal judge in New York has dismissed a proposed class action filed by health insurer Blue Cross Blue Shield of Louisiana ...

A New York City federal court has dismissed a proposed class action lawsuit against Bristol Myers Squibb that accused the ...

Find out how Bristol Myers Squibb was honored for 50 years of service in Lawrence, from local support to global medical ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Sell rating on Bristol-Myers Squibb (BMY – Research Report), with a ...

Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing sham patent ...

Bristol-Myers Squibb Co. got dismissal of a lawsuit alleging the company used reverse-payment agreements to delay the generic ...

Shares in major U.S. and European pharmaceutical companies fell sharply Wednesday, underperforming a broader market downturn, after U.S. President Donald Trump said the country would soon impose “a ...

The EU executive and top pharmaceutical companies shared a video call to address concerns over potential US tariffs on drugs ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

The pharmaceutical and healthcare sectors were previously viewed as a relative safe haven from the tariff-induced market turmoil. The Health Care Select Sector SPDR exchange-traded fund XLV fell 7.8% ...

The FDA has approved Opdivo plus Yervoy for the first-line treatment of MSI-H/dMMR colorectal cancer, supported by the Phase ...